Clinical Trial

Prevalence of Postpartum Depression Among Patients of the CHUM GARE Clinic

Study acronym: PPD-GARE
Completed
View on ClinicalTrials.gov →
Summary
Postpartum depression (PPD) is a frequent complication of the postnatal period but remains underdetected in routine clinical practice. This prospective clinical study, conducted at the high-risk pregnancy clinic of the CHUM, aims to estimate the prevalence of PPD among patients seen in postpartum follow-up. It also assesses the feasibility of implementing a standardized screening protocol that combines the administration of the Edinburgh Postnatal Depression Scale (EPDS) with a clinical decision-support algorithm to guide appropriate medical follow-up. The study also seeks to explore clinical characteristics associated with higher EPDS scores.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-07
notable Primary completion moved earlier: 2026-10 -> 2026-03-18 2026-07-07
minor Completion moved earlier: 2027-01 -> 2026-04-01 2026-07-07
Trial Details
NCT Number NCT07200323
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Conditions Post-partum Depression, Maternal Health, Mental Health Issue
Enrollment 100 participants
Start Date 2025-10-20
Primary Completion 2026-03-18 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-06